Radiation-Induced Fibrosis (RIF) in Head and Neck Squamous Cell Carcinoma (HNSCC): A Review
Cells · 11.12.2025 · 14 (24) · 1969
DOI: 10.3390/cells14241969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.12.2025. Verfasst von Molly E Muehlebach und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, United States Department of Defense, The University of Kansas Cancer Center.
Abstract (Originalsprache)
Radiation-induced fibrosis (RIF) refers to the aberrant and continuous induction of myofibroblast-mediated wound healing in response to radiation therapy (RT) and occurs in up to 50% of head and neck squamous cell carcinoma (HNSCC) patients post-RT. Frontline treatment consists of an anti-inflammatory agent, pentoxifylline, in combination with an antioxidant, Vitamin E, (PENTOX) along with palliative care agents such as corticosteroids, non-steroidal anti-inflammatory agents, muscle relaxants (i.e., botulinum toxin A), or physical therapy for alleviation of symptoms such as pain, inflammation, and lymphedema. However, while efficacious in stabilization and palliation of disease, PENTOX is one of the only established agents with confirmed anti-fibrotic effects in HNSCC. Alternative therapies such as hyperbaric oxygen therapy or superoxide dismutase show efficacy in alleviating acute radiation toxicities but lack a substantial reduction in fibrotic burden. Furthermore, experimental investigations into natural antioxidants, anti-fibrotic agents approved for idiopathic pulmonary fibrosis, mesenchymal stem cell therapy, and general nutritional support, indicate anti-RIF potential, but studies in HNSCC specifically are lacking. This review aims to characterize the pathogenesis of RIF development in the HNSCC disease setting and summarize promising anti-fibrotic agents under investigation for radiation-induced toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA.
- Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS 66160, USA.
- Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
ORCID-Profile: Molly E Muehlebach, Sidharth Pradeep, Levi Arnold, Anna E Arthur
Förderung
- NCI NIH HHS
- United States Department of Defense
- The University of Kansas Cancer Center
- University of Kansas Cancer Center
- Department of Defense
Zitieren
APA
Muehlebach, M. E., Pradeep, S., Chen, X., Arnold, L., Arthur, A. E., Gan, G. N., & Thomas, S. M. (2025). Radiation-Induced Fibrosis (RIF) in Head and Neck Squamous Cell Carcinoma (HNSCC): A Review. Cells, 14(24), 1969. https://doi.org/10.3390/cells14241969
Vancouver
Muehlebach ME, Pradeep S, Chen X, Arnold L, Arthur AE, Gan GN, et al. Radiation-Induced Fibrosis (RIF) in Head and Neck Squamous Cell Carcinoma (HNSCC): A Review. Cells. 2025;14(24):1969. doi:10.3390/cells14241969
BibTeX
@article{Muehlebach2025,
author = {Muehlebach, Molly E and Pradeep, Sidharth and Chen, Xin and Arnold, Levi and Arthur, Anna E and Gan, Gregory N and Thomas, Sufi Mary},
title = {Radiation-Induced Fibrosis (RIF) in Head and Neck Squamous Cell Carcinoma (HNSCC): A Review},
journal = {Cells},
year = {2025},
volume = {14},
number = {24},
pages = {1969},
doi = {10.3390/cells14241969}
}
EUVIMED